IL1RAP and acute myeloid leukemia: Although IL1RAP has been identified as an antigen for NKt-AML, we wished to determine if IL1RAP is also expressed by other AML subgroups, as one could envision that therapeutic strategies targeting this antigen could be extended to other AML subtypes.